Back to search

Article

Common genetic variants near <i>SLC2A2</i> and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trial

2025-10-08

Abstract excerpt

<h4>ABSTRACT</h4> Optimizing second-line therapy for type 2 diabetes is challenging due to interindividual variability in response. We conducted a pharmacogenomic genome-wide association study (GWAS) in the Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness (GRADE) Study to identify genetic predictors of glycemic response to insulin glargine, glimepiride, liraglutide, and sitagliptin, w...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6beabfbe-6457-52d3-aef1-f45687516821
DOI
10.1101/2025.10.07.25336827
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Common genetic variants near <i>SLC2A2</i> and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trialDOI 10.1101/2025.10.07.25336827
Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to SulfonylureasSemantic proximity
Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin.Semantic proximity
Implications of genetic variations, differential gene expression, and allele-specific expression on metformin response in drug-naïve type 2 diabetes.Semantic proximity
A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetesSemantic proximity
Complete loss of<i>SLC30A8</i>in humans improves glucose metabolism and beta cell functionSemantic proximity
The study to understand the genetics of the acute response to metformin and glipizide in humans (SUGAR-MGH): design of a pharmacogenetic resource for type 2 diabetes.Semantic proximity
Genome-wide association analysis identifies ancestry-specific genetic variation associated with medication response in the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH)Semantic proximity
Long-Term Efficacy and Safety of GLP-1R Agonist and SGLT2 Inhibitor Therapy in the General Population: A 2x2 Factorial Mendelian Randomization StudySemantic proximity
Heterogeneity of Treatment Effects of Glucose-lowering Drug Classes for Type 2 Diabetes: LEGEND-T2DM Network Real-World EvidenceSemantic proximity
Clinical Study on the Relationship between the SNP rs8192675 (C/C) Site of SLC2A2 Gene and the Hypoglycemic Effect of Metformin in Type 2 Diabetes.Semantic proximity
Pharmacogenetics of metformin response: a step in the path toward personalized medicine.Semantic proximity
Influence of SLC22A1 rs622342 genetic polymorphism on metformin response in South Indian type 2 diabetes mellitus patientsSemantic proximity
Select a neighboring publication to make it the new centre.